D-0833-2016 Class III Terminated

Recalled by AbbVie Inc. — North Chicago, IL

FDA drug recall D-0833-2016 was initiated by AbbVie Inc. on Mar 24, 2016 and is designated Class III. Reason for recall: Failed Content Uniformity Specifications The recall status is terminated (terminated Oct 20, 2016). Affected quantity: 307 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 27, 2016
Initiation Date
Mar 24, 2016
Termination Date
Oct 20, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
307 bottles

Product description

Zemplar (paricalcitol) capsules, 1 mcg, 30-count bottle, Rx Only, Mfd for AbbVie Inc. North Chicago, IL 60064, NDC 0074-4317-30.

Reason for recall

Failed Content Uniformity Specifications

Distribution pattern

Nationwide

Code information

Lot #1055586, Exp.1/21/ 2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0833-2016
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for AbbVie Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0833-2016. Report a data issue: hello@regdatalab.com.